Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-09

AUTHORS

Tulin Cagatay, Munevver Aydın, Sule Sunmez, Penbe Cagatay, Ziya Gulbaran, Ahmet Gul, Bahar Artım, Zeki Kilicaslan

ABSTRACT

The objective of this study is to estimate the incidence of active tuberculosis in patients with inflammatory diseases receiving tumor necrosis factor-alpha (TNF-alpha) antagonists and to figure out the characteristics of patients who develop tuberculosis. 702 patients with different inflammatory diseases receiving TNF-alpha antagonists were followed up from August 2005 to July 2008 at our department of chest disease. All patients had tuberculin skin test (TST) and postero-anterior chest radiograph (CXR) prior to anti TNF-alpha antagonist treatment. All patients with a TST result > or =5 mm or fibrotic lesions on CXR were administered chemoprophylaxis with isoniazid (INH) for 9 months. 6 (0.85%) patients developed active tuberculosis (4 pulmonary and 2 extrapulmonary) during the follow-up period. TST was found to be positive in 434 (61.8%) of the patients. Patients, who were already on immunosuppressive therapy and who were not, were compared for the difference in their TST results and no statistically significant difference was found. Chemoprophylaxis was administered overall to 583 (83.0%) patients among which 31 (5.3%) developed hepatotoxicity. Of the patients who developed active tuberculosis, all were decided to receive INH chemoprophylaxis, however, only three of them adhered proper treatment. Diagnostic accuracy of TST for detecting latent tuberculosis is high among patients with inflammatory diseases even in the setting of immunosuppression. The risk of development of active TB is increased in this group of patients despite chemoprophylaxis, but this risk remains within the acceptable limits even in a moderate-tuberculosis incidence country, if proper chemoprophylaxis regimen is adhered. More... »

PAGES

1459-1463

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00296-009-1170-6

DOI

http://dx.doi.org/10.1007/s00296-009-1170-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044811654

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19844718


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antitubercular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Early Diagnosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoniazid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tuberculosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cagatay", 
        "givenName": "Tulin", 
        "id": "sg:person.01040341465.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040341465.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ayd\u0131n", 
        "givenName": "Munevver", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sunmez", 
        "givenName": "Sule", 
        "id": "sg:person.01154570065.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154570065.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey", 
            "Department of Biostatistics, Cerrahpasa Medical Faculty, Cerrahpasa, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cagatay", 
        "givenName": "Penbe", 
        "id": "sg:person.01346773715.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346773715.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gulbaran", 
        "givenName": "Ziya", 
        "id": "sg:person.01271016465.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271016465.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey", 
            "Division of Rheumatology, Department of Internal Medicine, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gul", 
        "givenName": "Ahmet", 
        "id": "sg:person.0603062573.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603062573.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey", 
            "Division of Rheumatology, Department of Internal Medicine, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Art\u0131m", 
        "givenName": "Bahar", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istanbul University", 
          "id": "https://www.grid.ac/institutes/grid.9601.e", 
          "name": [
            "Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kilicaslan", 
        "givenName": "Zeki", 
        "id": "sg:person.0755372650.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755372650.32"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1086/421494", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000937813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1994", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001244816", 
          "https://doi.org/10.1186/ar1994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0966-842x(00)88864-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002911075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/ajrccm.161.supplement_3.ats600", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004046562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2004.029041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007121823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa011110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008362918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4065/76.6.653", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013084934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/iai.70.8.4591-4599.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013817072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.imlet.2006.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017887862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10067-007-0591-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024215959", 
          "https://doi.org/10.1007/s10067-007-0591-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10067-007-0591-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024215959", 
          "https://doi.org/10.1007/s10067-007-0591-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025079355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.11137", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026422849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02715694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029003396", 
          "https://doi.org/10.1007/bf02715694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02715694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029003396", 
          "https://doi.org/10.1007/bf02715694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1529-0131(200102)45:1<101::aid-anr90>3.0.co;2-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035462519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keh203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036818332"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(89)90676-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041265207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/030097402317255372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041797506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.293.22.2785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042421734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.11301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045148264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/kei103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051804569"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0025-6196(11)62418-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054591921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/clinids/17.6.968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059472715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074361122", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077310095", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078294404", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078314853", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-09", 
    "datePublishedReg": "2010-09-01", 
    "description": "The objective of this study is to estimate the incidence of active tuberculosis in patients with inflammatory diseases receiving tumor necrosis factor-alpha (TNF-alpha) antagonists and to figure out the characteristics of patients who develop tuberculosis. 702 patients with different inflammatory diseases receiving TNF-alpha antagonists were followed up from August 2005 to July 2008 at our department of chest disease. All patients had tuberculin skin test (TST) and postero-anterior chest radiograph (CXR) prior to anti TNF-alpha antagonist treatment. All patients with a TST result > or =5 mm or fibrotic lesions on CXR were administered chemoprophylaxis with isoniazid (INH) for 9 months. 6 (0.85%) patients developed active tuberculosis (4 pulmonary and 2 extrapulmonary) during the follow-up period. TST was found to be positive in 434 (61.8%) of the patients. Patients, who were already on immunosuppressive therapy and who were not, were compared for the difference in their TST results and no statistically significant difference was found. Chemoprophylaxis was administered overall to 583 (83.0%) patients among which 31 (5.3%) developed hepatotoxicity. Of the patients who developed active tuberculosis, all were decided to receive INH chemoprophylaxis, however, only three of them adhered proper treatment. Diagnostic accuracy of TST for detecting latent tuberculosis is high among patients with inflammatory diseases even in the setting of immunosuppression. The risk of development of active TB is increased in this group of patients despite chemoprophylaxis, but this risk remains within the acceptable limits even in a moderate-tuberculosis incidence country, if proper chemoprophylaxis regimen is adhered.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00296-009-1170-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093123", 
        "issn": [
          "0172-8172", 
          "1437-160X"
        ], 
        "name": "Rheumatology International", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis", 
    "pagination": "1459-1463", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d573ddd2acb9aae8b725f16c07187c15ac4f2375dd48e895388522af0db5a69e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19844718"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8206885"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00296-009-1170-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044811654"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00296-009-1170-6", 
      "https://app.dimensions.ai/details/publication/pub.1044811654"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13081_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00296-009-1170-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00296-009-1170-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00296-009-1170-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00296-009-1170-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00296-009-1170-6'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      70 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00296-009-1170-6 schema:about N016e71ace93341f88f594354c88e3bb3
2 N02965b930a994dd6942cb1245d1fe36b
3 N14e01b5d489b4e49abf5ab93418da02f
4 N39aa56cd4c2649b5b3c0b09fa3cd33b7
5 N59c65447f257416dbd7afe3283360fff
6 N60bde91f2ad146519800a5d8f46c2ff3
7 N8b45b7ce14734e158e8b6b38a136c6eb
8 N985b3bc0e8164c0cad5c68e441ceb36f
9 N9c1f8b2a4b5a465a80d71d47f4c1b71b
10 Na391a5cb6ddd4eaf96f447743b34734e
11 Nc5b1800ced1148858d75516b3fadad1e
12 Nd867b593f6334d03839203af1d62350c
13 Ne38184ad71d94927b71a47217b10f000
14 Nf0da5029ddb144cda297ea4b13f2f114
15 Nfa135335ad3741faa5091bf1c0f0a452
16 anzsrc-for:11
17 anzsrc-for:1107
18 schema:author N017247f7a63b4bdf9135bbb8e6c1dffb
19 schema:citation sg:pub.10.1007/bf02715694
20 sg:pub.10.1007/s10067-007-0591-4
21 sg:pub.10.1186/ar1994
22 https://app.dimensions.ai/details/publication/pub.1074361122
23 https://app.dimensions.ai/details/publication/pub.1077310095
24 https://app.dimensions.ai/details/publication/pub.1078294404
25 https://app.dimensions.ai/details/publication/pub.1078314853
26 https://doi.org/10.1001/jama.293.22.2785
27 https://doi.org/10.1002/1529-0131(200102)45:1<101::aid-anr90>3.0.co;2-7
28 https://doi.org/10.1002/art.11137
29 https://doi.org/10.1002/art.11301
30 https://doi.org/10.1002/art.20009
31 https://doi.org/10.1016/0092-8674(89)90676-4
32 https://doi.org/10.1016/j.imlet.2006.08.002
33 https://doi.org/10.1016/s0025-6196(11)62418-x
34 https://doi.org/10.1016/s0966-842x(00)88864-2
35 https://doi.org/10.1056/nejmoa011110
36 https://doi.org/10.1080/030097402317255372
37 https://doi.org/10.1086/421494
38 https://doi.org/10.1093/clinids/17.6.968
39 https://doi.org/10.1093/rheumatology/keh203
40 https://doi.org/10.1093/rheumatology/kei103
41 https://doi.org/10.1128/iai.70.8.4591-4599.2002
42 https://doi.org/10.1136/ard.2004.029041
43 https://doi.org/10.1164/ajrccm.161.supplement_3.ats600
44 https://doi.org/10.4065/76.6.653
45 schema:datePublished 2010-09
46 schema:datePublishedReg 2010-09-01
47 schema:description The objective of this study is to estimate the incidence of active tuberculosis in patients with inflammatory diseases receiving tumor necrosis factor-alpha (TNF-alpha) antagonists and to figure out the characteristics of patients who develop tuberculosis. 702 patients with different inflammatory diseases receiving TNF-alpha antagonists were followed up from August 2005 to July 2008 at our department of chest disease. All patients had tuberculin skin test (TST) and postero-anterior chest radiograph (CXR) prior to anti TNF-alpha antagonist treatment. All patients with a TST result > or =5 mm or fibrotic lesions on CXR were administered chemoprophylaxis with isoniazid (INH) for 9 months. 6 (0.85%) patients developed active tuberculosis (4 pulmonary and 2 extrapulmonary) during the follow-up period. TST was found to be positive in 434 (61.8%) of the patients. Patients, who were already on immunosuppressive therapy and who were not, were compared for the difference in their TST results and no statistically significant difference was found. Chemoprophylaxis was administered overall to 583 (83.0%) patients among which 31 (5.3%) developed hepatotoxicity. Of the patients who developed active tuberculosis, all were decided to receive INH chemoprophylaxis, however, only three of them adhered proper treatment. Diagnostic accuracy of TST for detecting latent tuberculosis is high among patients with inflammatory diseases even in the setting of immunosuppression. The risk of development of active TB is increased in this group of patients despite chemoprophylaxis, but this risk remains within the acceptable limits even in a moderate-tuberculosis incidence country, if proper chemoprophylaxis regimen is adhered.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree false
51 schema:isPartOf N26b92af75aba4bbdb0e6205c54a1b5a8
52 N853e21c8e7b741e8a45d62ad25047fd0
53 sg:journal.1093123
54 schema:name Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
55 schema:pagination 1459-1463
56 schema:productId N13475c5b12424d7aa77cb8ff1b053267
57 N89dfbc1a9f9a4812bf2f7e4550762ece
58 Nc415934ce511481dacbb9b8113f2c8fc
59 Nc859be4b321d4cd8be063b5ae8e0b95f
60 Ncd51a5beac65484fa369785c719832ac
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044811654
62 https://doi.org/10.1007/s00296-009-1170-6
63 schema:sdDatePublished 2019-04-11T14:28
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N1e0250c163014478bfe6f5c250e0ad4e
66 schema:url https://link.springer.com/10.1007%2Fs00296-009-1170-6
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N016e71ace93341f88f594354c88e3bb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Female
72 rdf:type schema:DefinedTerm
73 N017247f7a63b4bdf9135bbb8e6c1dffb rdf:first sg:person.01040341465.04
74 rdf:rest N438ab0c703364a9d8d0ca93323e2fb27
75 N02965b930a994dd6942cb1245d1fe36b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Predictive Value of Tests
77 rdf:type schema:DefinedTerm
78 N13475c5b12424d7aa77cb8ff1b053267 schema:name pubmed_id
79 schema:value 19844718
80 rdf:type schema:PropertyValue
81 N14e01b5d489b4e49abf5ab93418da02f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Adult
83 rdf:type schema:DefinedTerm
84 N1e0250c163014478bfe6f5c250e0ad4e schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N26b92af75aba4bbdb0e6205c54a1b5a8 schema:volumeNumber 30
87 rdf:type schema:PublicationVolume
88 N2ca64521b8134b9aad4b12c38f4ad86b rdf:first sg:person.01271016465.39
89 rdf:rest Ne9513ba54457435686acd1ad97488955
90 N2f65e7ce1148410da8f274ae315c935e schema:affiliation https://www.grid.ac/institutes/grid.9601.e
91 schema:familyName Artım
92 schema:givenName Bahar
93 rdf:type schema:Person
94 N39aa56cd4c2649b5b3c0b09fa3cd33b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Isoniazid
96 rdf:type schema:DefinedTerm
97 N3a584f57aa1a408ca04e2a666b547d3b schema:affiliation https://www.grid.ac/institutes/grid.9601.e
98 schema:familyName Aydın
99 schema:givenName Munevver
100 rdf:type schema:Person
101 N3f18b252efc84c58a4d798898bc45ccc rdf:first sg:person.01346773715.33
102 rdf:rest N2ca64521b8134b9aad4b12c38f4ad86b
103 N438ab0c703364a9d8d0ca93323e2fb27 rdf:first N3a584f57aa1a408ca04e2a666b547d3b
104 rdf:rest N99ce7e20d508450d9ec5cdb834fa71ce
105 N59850f61e08440bb83873649961649b1 rdf:first sg:person.0755372650.32
106 rdf:rest rdf:nil
107 N59c65447f257416dbd7afe3283360fff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Risk Factors
109 rdf:type schema:DefinedTerm
110 N60bde91f2ad146519800a5d8f46c2ff3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Risk Assessment
112 rdf:type schema:DefinedTerm
113 N853e21c8e7b741e8a45d62ad25047fd0 schema:issueNumber 11
114 rdf:type schema:PublicationIssue
115 N89dfbc1a9f9a4812bf2f7e4550762ece schema:name nlm_unique_id
116 schema:value 8206885
117 rdf:type schema:PropertyValue
118 N8b45b7ce14734e158e8b6b38a136c6eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 N985b3bc0e8164c0cad5c68e441ceb36f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Antitubercular Agents
123 rdf:type schema:DefinedTerm
124 N99ce7e20d508450d9ec5cdb834fa71ce rdf:first sg:person.01154570065.33
125 rdf:rest N3f18b252efc84c58a4d798898bc45ccc
126 N9c1f8b2a4b5a465a80d71d47f4c1b71b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Tuberculosis
128 rdf:type schema:DefinedTerm
129 Na391a5cb6ddd4eaf96f447743b34734e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Tumor Necrosis Factor-alpha
131 rdf:type schema:DefinedTerm
132 Nc415934ce511481dacbb9b8113f2c8fc schema:name readcube_id
133 schema:value d573ddd2acb9aae8b725f16c07187c15ac4f2375dd48e895388522af0db5a69e
134 rdf:type schema:PropertyValue
135 Nc5b1800ced1148858d75516b3fadad1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Immunosuppressive Agents
137 rdf:type schema:DefinedTerm
138 Nc859be4b321d4cd8be063b5ae8e0b95f schema:name doi
139 schema:value 10.1007/s00296-009-1170-6
140 rdf:type schema:PropertyValue
141 Ncd51a5beac65484fa369785c719832ac schema:name dimensions_id
142 schema:value pub.1044811654
143 rdf:type schema:PropertyValue
144 Nd867b593f6334d03839203af1d62350c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Middle Aged
146 rdf:type schema:DefinedTerm
147 Ne38184ad71d94927b71a47217b10f000 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Early Diagnosis
149 rdf:type schema:DefinedTerm
150 Ne9513ba54457435686acd1ad97488955 rdf:first sg:person.0603062573.29
151 rdf:rest Nf9b20c03750d4bef92d93d69c7558208
152 Nf0da5029ddb144cda297ea4b13f2f114 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Follow-Up Studies
154 rdf:type schema:DefinedTerm
155 Nf9b20c03750d4bef92d93d69c7558208 rdf:first N2f65e7ce1148410da8f274ae315c935e
156 rdf:rest N59850f61e08440bb83873649961649b1
157 Nfa135335ad3741faa5091bf1c0f0a452 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Male
159 rdf:type schema:DefinedTerm
160 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
161 schema:name Medical and Health Sciences
162 rdf:type schema:DefinedTerm
163 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
164 schema:name Immunology
165 rdf:type schema:DefinedTerm
166 sg:journal.1093123 schema:issn 0172-8172
167 1437-160X
168 schema:name Rheumatology International
169 rdf:type schema:Periodical
170 sg:person.01040341465.04 schema:affiliation https://www.grid.ac/institutes/grid.9601.e
171 schema:familyName Cagatay
172 schema:givenName Tulin
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040341465.04
174 rdf:type schema:Person
175 sg:person.01154570065.33 schema:affiliation https://www.grid.ac/institutes/grid.9601.e
176 schema:familyName Sunmez
177 schema:givenName Sule
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154570065.33
179 rdf:type schema:Person
180 sg:person.01271016465.39 schema:affiliation https://www.grid.ac/institutes/grid.9601.e
181 schema:familyName Gulbaran
182 schema:givenName Ziya
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271016465.39
184 rdf:type schema:Person
185 sg:person.01346773715.33 schema:affiliation https://www.grid.ac/institutes/grid.9601.e
186 schema:familyName Cagatay
187 schema:givenName Penbe
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346773715.33
189 rdf:type schema:Person
190 sg:person.0603062573.29 schema:affiliation https://www.grid.ac/institutes/grid.9601.e
191 schema:familyName Gul
192 schema:givenName Ahmet
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603062573.29
194 rdf:type schema:Person
195 sg:person.0755372650.32 schema:affiliation https://www.grid.ac/institutes/grid.9601.e
196 schema:familyName Kilicaslan
197 schema:givenName Zeki
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755372650.32
199 rdf:type schema:Person
200 sg:pub.10.1007/bf02715694 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029003396
201 https://doi.org/10.1007/bf02715694
202 rdf:type schema:CreativeWork
203 sg:pub.10.1007/s10067-007-0591-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024215959
204 https://doi.org/10.1007/s10067-007-0591-4
205 rdf:type schema:CreativeWork
206 sg:pub.10.1186/ar1994 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001244816
207 https://doi.org/10.1186/ar1994
208 rdf:type schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1074361122 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1077310095 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1078294404 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1078314853 schema:CreativeWork
213 https://doi.org/10.1001/jama.293.22.2785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042421734
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1002/1529-0131(200102)45:1<101::aid-anr90>3.0.co;2-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035462519
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1002/art.11137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026422849
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1002/art.11301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045148264
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1002/art.20009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025079355
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/0092-8674(89)90676-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041265207
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.imlet.2006.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017887862
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0025-6196(11)62418-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1054591921
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/s0966-842x(00)88864-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002911075
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1056/nejmoa011110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008362918
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1080/030097402317255372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041797506
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1086/421494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000937813
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1093/clinids/17.6.968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059472715
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1093/rheumatology/keh203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036818332
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1093/rheumatology/kei103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051804569
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1128/iai.70.8.4591-4599.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013817072
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1136/ard.2004.029041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007121823
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1164/ajrccm.161.supplement_3.ats600 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004046562
248 rdf:type schema:CreativeWork
249 https://doi.org/10.4065/76.6.653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013084934
250 rdf:type schema:CreativeWork
251 https://www.grid.ac/institutes/grid.9601.e schema:alternateName Istanbul University
252 schema:name Department of Biostatistics, Cerrahpasa Medical Faculty, Cerrahpasa, Istanbul, Turkey
253 Department of Pulmonary Diseases, Istanbul Faculty of Medicine, Capa, 34390, Istanbul, Turkey
254 Division of Rheumatology, Department of Internal Medicine, Istanbul, Turkey
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...